Showing results (651-660 of 673) with videos related to

Sort By:
Pageof 68
Annals of Hematology|February 21, 2020
RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO groupMariana Bastos-Oreiro, Ana Muntañola, Carlos Panizo, et al.
Journal of Hematology & Oncology|April 3, 2023
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registryFrancesco Marchesi, Jon Salmanton-García, Caterina Buquicchio, et al.
Transplantation and Cellular Therapy|April 10, 2021
Long-Term Outcomes After Autologous Versus Allogeneic Stem Cell Transplantation in Molecularly-Stratified Patients With Intermediate Cytogenetic Risk Acute Myeloid Leukemia: A PETHEMA StudyEduardo Rodríguez-Arbolí, David Martínez-Cuadrón, Rebeca Rodríguez-Veiga, et al.
Journal of Asthma and Allergy|August 12, 2024
Changes in Skin Test Aeroallergen Sensitization in Mexico Over the Past 14 Years and According to ClimateDésirée Larenas-Linnemann, Blanca María Morfín-Maciel, Victor Gonzalez-Uribe, et al.
Blood Advances|July 16, 2025
TAFASITAMAB PLUS LENALIDOMIDE AS SALVAGE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: REAL-WORLD EXPERIENCE FROM GELTAMOAntonio Gutierrez, Izaskun Zeberio, Francisco Javier Penalvar, et al.
Nature Communications|November 26, 2021
Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architectureEva G Álvarez, Jonas Demeulemeester, Paula Otero, et al.
Nature Cancer|October 2, 2023
Somatic evolution of marine transmissible leukemias in the common cockle, Cerastoderma eduleAlicia L Bruzos, Martín Santamarina, Daniel García-Souto, et al.
Cancer|January 3, 2025
Treatment patterns and outcomes in secondary acute myeloid leukemia arising after hypomethylating agents: PETHEMA registry studyPilar Lloret-Madrid, Blanca Boluda, Joaquín Martínez-López, et al.
Nanoscale Horizons|September 6, 2024
Plasmonic nanoparticle sensors: current progress, challenges, and future prospectsKrishna Kant, Reshma Beeram, Yi Cao, et al.
Cancer Medicine|May 22, 2023
Clinical outcomes after CPX-351 in patients with high-risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registryTeresa Bernal, Ainhoa Fernández Moreno, Almudena de LaIglesia, et al.
Pageof 68